The Latest Breaking News from Merck

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Recent market reaction to Trump administration policy announcements has been "entirely normal."

The Nasdaq dominated the major indexes Tuesday. Costco hit a new high and is in a buy zone.

Merck has considerably underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

The Dow Jones dropped Tuesday as China imposed tariffs on U.S. imports in response to President Trump's tariffs. Palantir surged on earnings.

Investors hammered Merck stock Tuesday after the company beat fourth-quarter expectations, but delivered a light 2025 outlook.

March S&P 500 E-Mini futures (ESH25) are down -0.21%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.11% this morning as investors adopted a cautious stance after China retaliated to new U.S. tariffs.

March S&P 500 E-Mini futures (ESH25) are down -0.01%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.08% this morning as investors awaited the latest reading on U.S. job openings, comments from Federal Reserve officials, and corporate earnings reports from heavyweight names.

President Donald Trump’s Health and Human Services nominee said he will divest his interest in lawsuits against an HPV vaccine manufacturer.

Biotech stocks will need to brace for political "games" Wednesday as the Senate meets to potentially confirm RFK Jr. to lead HHS.

Robert F. Kennedy, Jr. faces potential conflicts of interest as HHS secretary nominee due to financial ties with law firms handling litigation against drug...